Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on September 2, 2026

Sep. 2, 2026

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Maze Therapeutics to Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Climb Bio to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)

Indeterminate GlobeNewswire

Sep. 2, 2026

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Verano Announces Upcoming Conference Participation

Indeterminate GlobeNewswire

Sep. 2, 2026

Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

Indeterminate GlobeNewswire

Sep. 2, 2026

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 2, 2026

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 2, 2026

EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting

Indeterminate GlobeNewswire

Sep. 2, 2026

By Popular Demand: Tilray Beverages Makes Popsicle Hard Firecracker a Permanent Flavor

Indeterminate GlobeNewswire

Sep. 2, 2026

TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors

Indeterminate GlobeNewswire

Sep. 2, 2026

Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

Indeterminate GlobeNewswire

Sep. 2, 2026

Resalis Therapeutics Appoints Diana M. Røpcke as Chief Medical Officer

Indeterminate GlobeNewswire

Sep. 2, 2026

CDT Provides Capital Update and Confirms No Nasdaq Deficiencies

Indeterminate GlobeNewswire

Sep. 2, 2026

DoKegel Launches Personalized Pelvic Floor Training App for Men

Indeterminate GlobeNewswire

Sep. 2, 2026

Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

NewBiologix and Synastra Biotechnology Partner to Advance Stable rAAV Manufacturing for Duchenne Muscular Dystrophy Gene Therapy

Indeterminate GlobeNewswire